Allogenic NK Cell Transfusion Azacitidine MDS-EB
NCT04599426
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
MDS-EB
Interventions
BIOLOGICAL:
Allogeneic NK cell regimen group
Sponsor
The Second Hospital of Shandong University